Drug Targets – Products

Product News
GenNext Technologies Appoints Dr. Lisa Jones of UCSD to the Role of Chief Science Officer
GenNext Technologies, Inc. has selected Dr. Lisa Jones as the company’s new chief science officer.

Product News
Pheno Therapeutics Announces Worldwide License From UCB to a Novel Program for Neurodegenerative Disease
Pheno Therapeutics Limited has announced that it has entered into an exclusive worldwide license agreement with UCB.

App Note / Case Study
Consistency is Key to Further Drug Discovery Research
Energy metabolism plays a central role in a wide variety of cellular and physiological processes. Therefore, a deep understanding of how disruption to energy metabolism impacts cells can help in therapeutic drug discovery and development.

Product News
Foundational Partnership With Paradigm4 Enables Alnylam Pharmaceuticals To Accelerate RNAi-Based Drug Target Discovery
Paradigm4’s REVEAL Integrative Analytics platform enables Alnylam Pharmaceuticals to discover novel, genetically-validated drug targets from population scale biobank genotype-phenotype datasets and underlies the extraordinary pace and productivity of Alnylam’s RNAi therapeutics pipeline.

Product News
Ubiquigent Appoints Dr. Sheelagh Frame, CSO, to its Board of Directors
Ubiquigent Limited today announced the appointment of Dr. Sheelagh Frame, Chief Scientific Officer, to the Company’s Board of Directors.

Product
Advertisement
MACSima™ Imaging Platform – The Next Level of Context in Spatial Biology
The MACSima™ Imaging Platform opens the next level of context in spatial biology, allowing fully automated imaging of 100s of protein markers on a single tissue sample. It includes a broad portfolio of pre-validated antibodies and an easy-to-use software generating ready-to-publish images and charts.

Product News
bit.bio Adds Two New Human Cell Products To Accelerate Research and Drug Discovery for Neurodegenerative Disease
Cell coding company bit.bio has announced an expansion to its product portfolio to enable scientists to study neurodegenerative diseases in a human context.

Product News
Molecular Devices and HeartBeat.bio Announce Collaboration To Automate and Scale Cardiac Organoids
Molecular Devices, LLC. and HeartBeat.bio AG, a biotech company developing cardiac organoids for drug discovery, have entered into a co-development agreement.

Product News
PhoreMost Enters Multi-Project Drug Target Discovery Collaboration With Roche
PhoreMost Ltd. today announced it has entered into a multi-project target discovery collaboration with Roche.

Product News
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Bio-Rad Laboratories, Inc. today extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin, secukinumab and the secukinumab–interleukin 17A drug-target complex.
Advertisement